(NYSE: CHE) Chemed's forecast annual revenue growth rate of 6.17% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 66.01%.
Chemed's revenue in 2026 is $2,530,634,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $38,682,416,545, with the lowest CHE revenue forecast at $37,039,369,925, and the highest CHE revenue forecast at $40,764,553,210. On average, 3 Wall Street analysts forecast CHE's revenue for 2027 to be $40,311,298,970, with the lowest CHE revenue forecast at $38,951,536,250, and the highest CHE revenue forecast at $42,067,659,150.
In 2028, CHE is forecast to generate $42,223,465,295 in revenue, with the lowest revenue forecast at $40,977,016,135 and the highest revenue forecast at $43,894,840,305.